Predictive value of circulating microRNA-21 levels in patients with advanced non-small cell lung cancer treated with immunotherapy
MiR-21 levels were significantly correlated with the therapeutic effect and prognosis of NSCLC patients who received immunotherapy. MiR-21 holds promise as a potential biomarker of response to immunotherapy in NSCLC and it may suggest that miR-21 could be regarded as a novel indicator for prognostic prediction in NSCLC patients.
Authors
- Shan Jiang (ORCID: https://orcid.org/0000-0002-1540-8506)
- Xu Xu (ORCID: https://orcid.org/0009-0003-5844-6208)
- Cong Wang (ORCID: https://orcid.org/0000-0003-2626-9596)
- Junfang Bi (ORCID: https://orcid.org/0009-0009-7734-6660)
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Jining Traditional Chinese Medicine Hospital (CN)
- Hebei University of Chinese Medicine (CN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2025-09-16
- DOI
- https://doi.org/10.3332/ecancer.2025.1989
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00